Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Cipla, Eli Lilly and India

Digest more
Stocktwits on MSN · 2d
Cipla Shares Fall To Biggest Intra-day Lows In Six Months Despite Eli Lilly Deal For Diabetes Drug
Cipla-Eli Lilly partner to distribute Tirzepatide under the Yurpeak brand in India ・Tirzepatide is used to manage type 2 diabetes and chronic weight issues in adults ・The stock has outperformed the broader pharma index YTD Shares of Cipla fell 3.

Continue reading

 · 3d · on MSN
Eli Lilly gives Cipla license to sell weight-loss drug Tirzepatide in India
 · 2d
Cipla shares fall 3% after Eli Lilly deal to market weight-loss drug in India: Here's what analysts say
The Pharma Letter
1d

Cipla and Eli Lilly partner to launch tirzepatide as Yurpeak in India

Indian drugmaker Cipla Limited has entered into a strategic marketing and distribution agreement with US pharma major Eli ...
4don MSN

3 Things Investors Need to Know Ahead of Eli Lilly's Q3 Earnings Report

On Oct. 30, Eli Lilly will announce third-quarter earnings results that could lift the stock, or pressure it further. Here ...
2h

Eli Lilly: Is Another Monster Quarter Coming

October 30th is the day when Eli Lilly will report its third-quarter results, including sales of its 'superstars' Zepbound ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
  • Privacy
  • Terms